Status:
UNKNOWN
Gene Expression Changes of Brain Tissue in Human Temporal Lobe Epilepsy With Hippocampal Sclerosis
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Epilepsy
Hippocampal Sclerosis
Eligibility:
All Genders
Brief Summary
Epilepsy is a common neurological disease, manifested in the sudden abnormal discharge of neurons leading to short-term brain dysfunction, has become the neurology after headache the second most commo...
Eligibility Criteria
Inclusion
- Patients confirmed in our hospital as having temporal lobe epilepsy and intending surgery to remove temporal lobe and hippocampal tissue;
- Volunteer to participate in this clinical trial, comply with the requirements of this clinical trial and sign an informed consent form.
Exclusion
- Chronic diseases of the central nervous system other than temporal lobe epilepsy;
- Other patients that are not suitable for this clinical trial determined by the researchers;
Key Trial Info
Start Date :
April 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04917939
Start Date
April 19 2021
End Date
December 1 2022
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, China